Mölnlycke Health Care reaches 100% renewable electricity target
Gothenburg, Sweden. 29 January 2025. Mölnlycke, a world leading MedTech company, has secured 100% renewable electricity for all its established and new manufacturing sites and its headquarters, reaching its first near-term SBTi (Science Based Targets initiative)-validated target.
“This is a significant milestone in Mölnlycke’s commitment to halving Scope 1 and 2 greenhouse gas emissions by 2030” said Caterina Camerani, VP Sustainability at Mölnlycke, “It propels us towards our vision of building a sustainable healthcare manufacturing ecosystem.”
A major enabler in reaching the goal was signing two virtual Power Purchase Agreements (vPPAs) for the regions where the company has the highest manufacturing footprint. To cover electricity consumption for the sites in the European Union, Mölnlycke signed a long-term vPPA committing to purchasing renewable electricity generated in Mutkalampi, the largest wind farm in Finland. The three manufacturing plants in Malaysia will handle their renewable electricity needs through a similar vPPA from a newly established solar power plant in Bukit Kayu Hitam, Malaysia. In addition, Mölnlycke continues to invest in on-site generation of solar energy with manufacturing sites in Malaysia and the UK having completed the installation of rooftop solar panels and the installation on factories in Thailand ongoing.
The remaining electricity consumption needs for the established manufacturing sites are met through sourcing renewable electricity from the grid (the UK, HQ) or a combination of renewable grid electricity and Renewable Energy Certificates (RECs) (the US). Finally, the plants in Thailand, as well as the newly established plant in the Kingdom of Saudi Arabia purchase Renewable Energy Certificates (RECs). As stated in the near-term goal validated by SBTi, Mölnlycke will continue active sourcing of renewable electricity through 2030.
-Ends-
For more information, please contact:
Sofia Lindqvist
Media & Financial Communications Manager
Email: sofia.lindqvist@molnlycke.com
Phone: +4672 255 35 09
About Mölnlycke®
Mölnlycke Health Care is a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures. Mölnlycke products and solutions are used daily by hospitals, health care providers and patients in over 100 countries around the world. Founded in 1849, Mölnlycke is owned by Investor AB and headquartered in Sweden. www.molnlycke.com
Tags:
